PP
SQZ

PDT Partners’s SQZ Biotechnologies Company SQZ Stock Holding History

PDT Partners’s Portfolio SQZ Stock Details SQZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-11,740
Closed -$37K – 1157
2022
Q2 		$37K Hold
11,740
– – ﹤0.01% 924
2022
Q1 		$56K Sell
11,740
-1,037
-8% -$6.58K ﹤0.01% 902
2021
Q4 		$114K Buy
+12,777
New +$157K 0.01% 813

Other funds holding SQZ

Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
AIG
American International Group New York $609M AUM 23.67% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
N
NanoDimension Woodside, California $24.7M AUM 74.01% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PDT Partners's SQZ Position: Q3 2022 in Review

PDT Partners sold out of SQZ Biotechnologies Company (SQZ) in Q3 2022, closing a stake of 11,740 shares — an estimated $37K sold.

PDT Partners first reported a position in SQZ in Q4 2021 and held it in 3 quarters. The position peaked at $114K in Q4 2021. 48 funds tracked by Wall St. Rank hold SQZ as of Q3 2022.

  • PDT Partners reported no remaining SQZ Biotechnologies Company position as of Q3 2022 after selling out during the quarter.
  • PDT Partners sold 11,740 SQZ Biotechnologies Company shares in Q3 2022, an estimated $37K.
  • PDT Partners first reported a position in SQZ Biotechnologies Company in Q4 2021 and held it in 3 quarters.
  • PDT Partners's SQZ Biotechnologies Company position peaked at $114K in Q4 2021.
  • 48 funds tracked by Wall St. Rank held SQZ Biotechnologies Company as of Q3 2022.

Based on PDT Partners's 13F filing for Q3 2022, filed 14 Nov 2022.